Late Graft Loss

1. Chronic graft loss in kidney and heart transplant recipients.- 2. Histopathology of chronic rejection.- 3. Evaluation of biopsy changes in the early diagnosis of chronic transplant nephropathy.- 4. Is there any relationship between the early glomerular filtration rate and late graft dysfunction in renal transplantation?.- 5. Transplantation atherosclerosis: Definition and pathogenesis.- 6. Immunological mechanism of chronic rejection.- 7. The role of adhesion molecules in chronic rejection.- 8. A role for TH2 cells in chronic allograft rejection?.- 9. Treatment of refractory acute allograft rejection with aerosolized cyclosporin in lung transplant recipients.- 10. Ischemia-reperfusion injury as a risk factor for late kidney graft failure.- 11. The impact of acute rejection in the longterm outcome after renal transplantation.- 12. Nephron endowment and the pathogenesis of chronic renal failure.- 13. Are child donors better than adult donors for pediatric kidney recipients?.- 14. Late graft loss in combined kidney-pancreas transplantation.- 15. Longterm allograft outcome in patients treated with prophylactic antilymphocyte globulin or OKT3 as induction therapy in cadaveric kidney transplantation.- 16. Cyclosporin - longterm treatment.- 17. Effect of new immunosuppressive drugs on chronic rejection.- 18. Experimental transplantation in rats for the study of the pathogenesis and treatment of chronic rejection.- 19. The effects of HMG-CoA reductase inhibitors after kidney and heart transplantation: Lipid lowering and immunosuppression.- 20. Lipid metabolism alteration and treatment in heart transplant recipients.- 21. Prevention and treatment of cytomegalovirus (CMV) disease.- 22. Longterm renal function protection in renal transplantation by nonimmunological treatments.-Clinical impact and predictive role of OGTT as a marker of longterm loss of function in patients submitted to pancreas transplantation.- Influence of recipient - donor body weight ratio in pediatric renal transplantation.- Survival, rejection, tumors and infections 5 years after liver transplantation.- Comparison of dipyridamole thallium scintigraphy and dobutamine stress echocardiography to detect graft coronary artery disease in heart transplant patients.- Immunohistochemical profile in asymptomatic acute rejection of renal allografts: Predictive marker of graft loss.- High sodium UW cold-storage solution improves kidney graft function in rats.- Influence of natural selection haplotypes on longterm survival in renal transplantation from haploidentical living related donors.- Posttransplant immunological monitoring by ELISA: HLA-specific IgG antibodies are associated with early and late graft loss events.- Longterm benefit of additional azathioprine in cyclosporin/prednisolone-treated patients with chronic renal allograft dysfunction.- Effect of steroid withdrawal on late immunologic complications after liver transplantation.- Effect of angiotensin converting enzyme inhibitors (ACEI) on the progressive graft failure and proteinuria in kidney transplant patients with chronic rejection.- ATG prophylaxis preoperatively reduced acute rejections - a predicting factor on long graft survival.- Kidney transplantation in children at our center.- Kidney transplantation between spouses.- Oxidative stress and lipid abnormalities during chronic rejection of kidney transplantation.- Proton NMR spectroscopy as a novel approach to the assessment of function in the pig isolated kidney exposed to cold ischemia.- Renal handling of citrate excretion during reperfusion after cold storagein the isolated perfused pig kidney.- The improvement of early rat kidney graft function after perfusion with HTK solution supplemented with pentoxifylline.- Nifedipine improves kidney function after 24 h cold storage in a high-sodium UW solution.- Preventing cadaveric grafted kidney from acute rejection with anti-thymocyte globulin.- Study of the pharmacokinetics of the Neoral® formulation of cyclosporin in vivo.- One-year results of the European mycophenolate mofetil phase III in clinical trial in renal transplantation.- Detection of lymphocyte panel reactive antibody (PRA) use in kidney transplantation.- Cholestatic and HCV-related liver disease associated with acute rejection after liver transplantation.- Outcome of children and adolescents with recurrent nephrotic syndrome (NS) and focal segmental glomerulosclerosis (FSGS) after renal transplantation.- CD8+ T lymphocytes can amount to a second-set rejection of skin allografts in the absence of cytotoxic antibodies.- Hyperimmune globulin in the prevention of cytomegalovirus infection: Lack of efficacy in kidney graft recipients.- Lung and heart lung transplantation: Survival data concerning 100 transplants carried out in 95 patients at the L. Pradel University Hospital, Lyon.- Evolution of lipoprotein(a) and concentration 6 months after a successful renal transplantation.- GSTs: Sensitive and specific markers for liver transplant monitoring.- Is overweight a relevant risk factor in the short- and longterm evolution of renal transplantation?.- Renal allograft thrombosis (rat): A case-control study.- A prospective study on the effect of kidney transplantation (KT) and cyclosporin treatment on male sexual performance and hormonal profiles.- Iliac artery histology and renal allograft blood flow measured by Dopplerspectrum analysis.- Blood flow impairment in popliteal and posterior tibial arteries after iliac end-to-side anastomosed renal transplantation.- The first kidney transplantation from spouse in Lithuania.- Name Index.